| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |